QSAR modeling of some substituted benzimidazole as Angotensin II AT1 receptor antagonist

Medicinal Chemistry Research

Volumn 19, Issue 2, 2010, Pages 177-185

  Jain, Anurekha ^a   Chaturvedi, S C ^b  

^a B R NAHATA COLLEGE OF PHARMACY   (India)

^b DEVI AHILYA UNIVERSITY   (India)

Author keywords

Angiotensin II antagonist; AT1 and AT2 receptor; Fuzita ban; Hansch analysis; Hypertension; Quantitative structure activity relationship; Sartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BENZIMIDAZOLE DERIVATIVE;

ARTICLE; COMPUTER PREDICTION; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTRIC ACTIVITY; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THERMODYNAMICS;

EID: 77953322778     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9182-z     Document Type: Article

References (14)

1. Carini DJ, Duncia JV, Aldrich PE, Chiu AT, Johnson AL, Pierce ME, Price WA, Snatella JB, Wells GJ, Wexler RR, Wong PC, Yoo SE, Timmermans PBMWM (1991) Nonpeptide angiotensin II receptor antagonist: the discovery of a series of N-{biphenyl methyl}imidazole as potent orally active hypertensive. J Med Chem 34:2525-2547
2. Csizmadia IG (1976) Theory and practice of MO calculations on organic molecules. Elsevier, Amsterdam
3. Dhondge R, Chaturvedi SC (2008) QSAR analysis of 2-sulfonyl phenyl 1-3-phenyl-indole derivative as a novel anti-inflammatory compounds. Med Chem Res. doi: 10.1007/80004-008-9117-0
4. Fujita T (1990) The extra thermodynamic approach to drug design. Comprehen Med Chem 4:497-560
5. Kubiny H (1994) Variable selection in QSAR studies. I. An evolutionary algorithm. Quant Struct Act Relat 13:285-294
6. Kubo K, Yasuhisa K, Imamiya E, Yoshihiro S, Inada Y, Furukawa Y, Nishikawa NT (1993) Nonpeptide angiotensin II receptor antagonist synthesis and biological activity of benzimidazole carboxylic acids. J Med Chem 36:1772-1784
7. Pals DT, Denning GS, Keenam RE (1971) Historical development of Saralasin. Kidney Int 15:S7-S10
8. Pandya T, Chaturvedi SC (2004) QSAR study of a series of 2,3,6-substituted quinazolinones as AT1 selective angiotensin II receptor antagonists. Indian J Chem B 43:2440-2445
9. Pandya T, Chaturvedi SC (2005) Structure activity relationship triazolinone-based compounds with antagonistic balanced activity on angiotensin II receptor subtype AT1 and AT2/a three-dimensional structure activity relationship investigation. Arzneimittelforschung 55:265-270
10. Soni LK, Rao PH, Sambasivarao SV, Gupta AK, Arockia BM, Kaskhedikar SG (2003) 3D-QSAR analysis of oxadiazole substituted α-isopropoxy phenylpropionic acids as PPAR-α & PPAR-γ agonists. Ind Drugs 40:627-635
11. Soni LK, Gupta AK, Khaskedikar SG (2008) QSAR study of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors. Med Chem Res 17:258-266
12. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251
13. Tiziano T, Vincenzo C, Simona R, Adriano M (2006) Proposal of a new binding orientation for nonpeptide AT1 antagonists: homology modeling, docking and three dimensional quantitative structure-activity relationship analysis. J Med Chem 49:4305-4316
14. Villanueva GM, Gutierrez PN, Martinez RA, Robles J (2005) Quantitative structure-property relationships to estimate nematic transition temperatures in thermotropic liquid crystals. J Mol Struct 727:63-69